Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,850,774
+$11,345,501 QoQ
Shares Held
62,412
+238.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#864
of 4,676 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Dec 31, 2025CallValue
$6,208,500
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brevan Howard Capital Management LP holds $180,596,811 across 9 Drug Manufacturers - General names. JNJ ranks #3 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
77,094 | $92,468,863 | |
| 2 | ABBV |
AbbVie Inc.
|
115,264 | $29,005,032 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
62,412 | $15,850,774 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
123,329 | $15,581,385 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
163,962 | $9,447,490 | |
| 6 | AMGN |
Amgen Inc
|
18,788 | $6,803,510 | |
| 7 | MRK |
Merck & Co., Inc.
|
50,031 | $6,428,983 | |
| 8 | AZN |
Astrazeneca PLC
|
20,152 | $3,821,222 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,850,774 | 62,412 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,505,273 | 18,431 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,386,802 | 55,022 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $6,208,500 | 30,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $15,509,455 | 83,645 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $21,647,577 | 141,719 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,617,905 | 64,025 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $3,089,025 | 19,061 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,929,657 | 26,886 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $807,876 | 5,107 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $308,852 | 1,983 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||